169 results on '"Keyzner, Alla"'
Search Results
2. Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study
3. TSC-100 and TSC-101, TCR-T Cell Therapies That Target Residual Recipient Cells after Reduced Intensity Conditioning Transplantation, Induce Complete Donor Chimerism with Favorable Prognosis: Early Results of a Phase 1 Trial
4. Characterization of Infectious Complications during the Expected Duration of Cytokine Release Syndrome (CRS) in Patients Receiving CAR T Cell Therapy – Are We over-Treating with Anti-Microbials?
5. Autoimmune hematologic complications of umbilical cord blood transplantation
6. Peritransplantation Use of Ruxolitinib in Myelofibrosis
7. Dynamics of cytomegalovirus‐specific T‐cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilot study.
8. Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
9. 682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation
10. Contributors
11. Posttransplant Lymphoproliferative Disorders and Immunodeficiency
12. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis
13. The Amyloidoses
14. Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration
15. A Pilot Study: Dynamics of CD4+ and CD8+ CMV-Specific T Cell Responses in Allogeneic Hematopoietic Cell Transplantation Using a Commercially Available CMV T-Cell Immunity Panel
16. Contributors
17. Primary Myelofibrosis
18. Haploidentical Donor Transplantation with Posttransplantation Cyclophosphamide in Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Institutional Collaboration of 14 Centers
19. Prognostic Impact of Day 14 Bone Marrow (D14 BM Bx) in Acute Myeloid Leukemia (AML) in the Setting of European Leukemianet (ELN) Risk Classification
20. Central Nervous System Specific Characteristics and Outcomes in Acute Myeloid Leukemia Patients with Neurologic Involvement
21. Chapter 72 - Primary Myelofibrosis and Chronic Neutrophilic Leukemia
22. MPN-452 ALLogeneic Stem Cell Transplant in Myelofibrosis Patients: A Real-World Analysis
23. Allogeneic Stem Cell Transplant in Myelofibrosis Patients: A Real-World Analysis
24. Acceptability of a machine learning-powered clinical decision support system aiding serious illness conversation and its impact on clinical outcomes: A pilot study.
25. Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
26. Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
27. Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study
28. Implementing clinical decision support for oncology advanced care planning: A systems engineering framework to optimize the usability and utility of a machine learning predictive model in clinical practice.
29. Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
30. 16 - Posttransplant Lymphoproliferative Disorders and Immunodeficiency
31. Hematopoietic stem cell transplant–associated thrombotic microangiopathy: review of pharmacologic treatment options
32. The Case | Proteinuria in a patient with hematopoietic stem cell transplantation
33. Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm
34. Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies
35. Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
36. An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy
37. 571. “Real world” Impact of Letermovir for Prevention of Cytomegalovirus Infection in Hematopoietic-Cell Transplantation
38. 425 - A Pilot Study: Dynamics of CD4+ and CD8+ CMV-Specific T Cell Responses in Allogeneic Hematopoietic Cell Transplantation Using a Commercially Available CMV T-Cell Immunity Panel
39. Contributors
40. Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum
41. AN UNUSUAL CASE OF AUTOIMMUNE NEUTROPENIA AND ANEMIA POST-UMBILICAL CORD BLOOD TRANSPLANTATION
42. Acute kidney injury after ruxolitinib: Common complication, uncommon cause
43. No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Compared to Conventional CBT: Results of a Randomized Trial
44. Prognostic Significance of Hospitalization Status at Second Cycle of Hypomethylating Agent Induction Therapy in Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
45. Pre‐clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice
46. Chapter 70 - Primary Myelofibrosis
47. Allogeneic Stem Cell Transplantation for AML and MDS
48. A lymphoma patient with Cytomegalovirus retinitis and post‐autologous hematopoietic cell transplantation immune reconstitution uveitis: A case report and review of the literature
49. Dose-Adjusted Intensive Chemotherapy Is Safe and Tolerable in Older Patients with Ph-Negative ACUTE Lymphoblastic Leukemia
50. The Effect of JAK 1/2 Inhibitors on Outcomes of Allogeneic Stem Cell Transplantation for Patients with Myelofibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.